BiPER Therapeutics is developing a first-in-class pipeline of therapeutics overstressing cells to cure patients. The company’s lead compound, BPR001, is a first-in-class small molecule therapeutic targeting BiP, an oncogenic protein shown to have a critical role in cancer
Company Details
- Employees
- 8
- Founded
- 2021
- Address
- 11 Rue De L Academie, Strasbourg,64000,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.biper-tx.com/
- Keywords
- Paris.
- HQ
- STRASBOURG
Biper Therapeutics Questions
Biper Therapeutics's website is https://www.biper-tx.com/
Biper Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/biper-therapeutics
Biper Therapeutics has
8 employees.
View email and phone details for 8
employees at Biper Therapeutics.
Biper Therapeutics's industry is
Biotechnology Research
Biper Therapeutics's top competitors are
Elicit Plant,
G.clips Biotech,
Agicap International,
Teeptrak,
Omaha Insights,
Dianosic,
Meet My Mama,
Serenysun Energies,
Iadys,
Roca Therapeutics.
Biper Therapeutics's categories are Biotechnology Research
Biper Therapeutics's founding year is 2021
